Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-12 09:11 am Purchase | 13G | Akoya Biosciences Inc. AKYA | PSC Capital Partners LLC | 3,517,360 7.200% | 800,000 (+29.44%) | View |
| 2023-02-15 09:15 am Unchanged | 13G | Akoya Biosciences Inc. AKYA | PSC Capital Partners LLC | 2,717,360 7.200% | 0 (Unchanged) | View |
| 2023-02-14 3:47 pm Sale | 13G | Akoya Biosciences Inc. AKYA | PSC Capital Partners LLC | 2,717,360 7.200% | -96,411 (-3.43%) | View |
| 2022-02-25 10:57 am Unchanged | 13G | Akoya Biosciences Inc. AKYA | PSC Capital Partners LLC | 2,813,771 7.600% | 0 (Unchanged) | View |
| 2022-02-14 12:56 pm Purchase | 13G | AKOYA BIOSCIENCES INC AKYA | PSC Capital Partners LLC | 2,813,771 7.600% | 2,813,771 (New Position) | View |